Dr. Ferrone is the Surgical Director of the Liver Program in the Division of General Surgery at Massachusetts General Hospital. She has 22 years of experience and her specialties include surgical oncology and surgery. She focuses in gastrointestinal malignancies and metastatic liver disease, immunologic treatment of solid tumors and GI malignancies and primary hepatic and pancreatic cancers.
Dr. Spicer is the associate Professor of Clinical Medicine and Chief of the Division of Medical Oncology at USC Norris Comprehensive Cancer and Hospital. He chairs Keck's Institutional Review Board. He is also a medical oncology attending physician at both theLAC+USC Medical Center and the USC Norris Comprehensive Cancer Center and the General Medicine Ward Attending Physician at LAC+USC Medical Center. Dr. Spicer is the founder of Balance Pharmaceuticals based in Los Angeles.
Dr. Rosenstock is the Dean Emeritus of UCLA Fielding School of Public Health. She also serves as the Chairperson of the Board of TSO3 Inc., Professor of Health Policy and Management, and Professor of Environmental Health Sciences and Medicine at UCLA. Dr. Rosenstock focuses on clinical care, health care delivery, population health, research and health and regulatory policy. She also served as Director of the National Institute for Occupational Safety and Health where she created the National Occupational Research Agenda- a framework for guiding occupational safety and health research- to identify and address pressing workplace health risk.
Associate Professor of Surgery (General Surgery) at the Stanford University Medical Center. Dr. Poultsides specializes in the removal of liver, pancreatic, and other abdominal tumors. He is currently researching outcomes analysis following multidisciplinary treatment of hepatic, pancreatic and gastrointestinal malignancies. He also developed a novel interdisciplinary research program assessing the completeness of surgical resection for pancreatic cancer. Dr. Poultsides is a recipient of the John AustinCollins, MD annual teaching award from the Stanford Surgery.
Associate Professor of Surgery at the Cleveland Clinic, where he also serves as the Director of Robotic Endocrine Surgery and co-director of Liver Tumor Ablation Program. His specialties include laparoscopic and robotic liver surgery, laparoscopic liver tumor ablation, robotic surgery, conventional and minimally invasive endocrine surgery (thyroid, parathyroid, adrenal and pancreas). Dr. Berber has authored120 peer-reviewed papers and 15 book chapters. He serves on the Editorial Board of Surgical Laparoscopy and Endoscopy. He is a member of numerous surgical societies, including American College of Surgeons and serves in multiple committees.
Jonathan is an active investor and operating advisor to a number of technology based companies across the world. Until recently, Jonathan was a senior executive at Uber, leading Uber’s FinTech Practice Globally and US Business Development. Prior to that, he ran Uber’s worldwide partnerships with Travel and Entertainment companies and helped to scale the 100+ person Uber Business team as one of its earliest members.
Jonathan spent the last two decades in senior roles across a variety of high growth technology companies. Prior to Uber, he served as SVP of Business Development and a member of the founding team at Swipely (now Upserve), one of the fastest growing payment companies in the US and part of Vista Equity Partners’ portfolio. Before Upserve, Jonathan was one of the first employees at Silicon Valley based Tellme, which revolutionized speech recognition systems and is used by millions of Americans daily. In 2007, Microsoft acquired Tellme in its then largest acquisition of a private company.
Jonathan began his career in private equity at Valor Equity Partners. He is an honors graduate of Vanderbilt University and lives in Charleston, SC with his wife and three young boys.